Literature DB >> 32897500

Bisphosphonate-related osteonecrosis induced change in alveolar bone architecture in rats with participation of Wnt signaling.

Vanessa Costa de Sousa Ferreira1,2, Amanda Pimentel Lopes1,2, Nicholas Militão Alves1,2, Fatima Regina Nunes Sousa1, Karuza Maria Alves Pereira1,2, Delane Viana Gondim1,2, Vírginia Claúdia Carneiro Girão1, Renata Ferreira Carvalho Leitão1, Paula Goes3,4,5.   

Abstract

OBJECTIVE: This work aimed to study the role of inflammation in medication-related osteonecrosis of the jaw (MRONJ) in rats with focus on Wnt signaling.
METHODS: A total of 36 female Wistar rats (12 weeks ± 200 g) were divided into 2 groups (n = 6) in 3 experiments: saline (SAL) and zoledronic acid (ZOL). For MRONJ induction, rats received 0.1 mg/kg of ZOL (ip) 3×/week for 9 weeks. Animals from the SAL group received 0.1 mg/kg of 0.9% SAL, ip 3×/week for 9 weeks. On the 8th week, 3 left upper molars were extracted, and on the 11th week, they were euthanized. Maxillae were evaluated by macroscopic and histopathological analyses; scanning electron microscopy (SEM); immunohistochemistry for DKK-1, Wnt 10b, and caspase-3; and Raman spectrometry. Gingiva was also collected for TNF-α e IL-1β quantification.
RESULTS: Bone necrosis was confirmed by healing impairment, reduced number of viable osteocytes, increased caspase-3 immunoexpression, and increased number of empty lacunae (p < 0.05). ZOL enhanced inflammation and increased gingival levels of IL-1β and TNF-α (p < 0.05). Irregular indentations were seen on bone after ZOL administration. Bone necrosis was marked by reduced amount of total and type I collagen. ZOL reduced the mineral/matrix ratio and increased carbonate/phosphate ratio. It was observed a significant reduction on Wnt10b and beta-catenin immunolabeling in the bone tissue of ZOL group.
CONCLUSION: In summary, MRONJ model caused bone necrosis due to intense inflammation. Wnt signaling seems to play an important role in this process. CLINICAL RELEVANCE: New therapeutic strategies focusing on Wnt pathway can provide an interesting approach for future treatments.

Entities:  

Keywords:  Bisphosphonates; Bone architecture; Inflammation; Osteonecrosis; Wnt signaling; Zoledronic acid

Year:  2020        PMID: 32897500     DOI: 10.1007/s00784-020-03551-7

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  35 in total

Review 1.  Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management.

Authors:  Salvatore L Ruggiero; Bhoomi Mehrotra
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

2.  Zoledronic acid modulates human osteosarcoma cells proliferation via GSK-3β activation.

Authors:  S Li; J J Li
Journal:  Neoplasma       Date:  2019-06-18       Impact factor: 2.575

Review 3.  Osteocyte apoptosis.

Authors:  Robert L Jilka; Brendon Noble; Robert S Weinstein
Journal:  Bone       Date:  2012-12-11       Impact factor: 4.398

4.  Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy.

Authors:  Tilman D Rachner; Uwe Platzbecker; Dieter Felsenberg; Lorenz C Hofbauer
Journal:  Mayo Clin Proc       Date:  2013-04       Impact factor: 7.616

5.  Histopathological features of bisphosphonates related osteonecrosis of the jaw in rats with and without vitamin d supplementation.

Authors:  Saim Yanık; Mutan Hamdi Aras; Suna Erkılıç; Zehra Bozdağ; Tuncer Demir; Sedat Çetiner
Journal:  Arch Oral Biol       Date:  2016-01-11       Impact factor: 2.633

6.  Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.

Authors:  Marcia P Maahs; Alan A Azambuja; Maria M Campos; Fernanda G Salum; Karen Cherubini
Journal:  Head Neck       Date:  2011-02       Impact factor: 3.147

Review 7.  Secreted antagonists of the Wnt signalling pathway.

Authors:  Yoshiaki Kawano; Robert Kypta
Journal:  J Cell Sci       Date:  2003-07-01       Impact factor: 5.285

Review 8.  Osteonecrosis of the jaw.

Authors:  Nelson B Watts; Robert D Marciani
Journal:  South Med J       Date:  2008-02       Impact factor: 0.954

9.  Protective mechanisms of simvastatin in experimental periodontal disease.

Authors:  Roberta Dalcico; Adriana M A de Menezes; Otacilio B Deocleciano; Reinaldo B Oriá; Mariana L Vale; Ronaldo A Ribeiro; Gerly A de C Brito
Journal:  J Periodontol       Date:  2012-11-26       Impact factor: 6.993

Review 10.  Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.

Authors:  Aliya A Khan; Archie Morrison; David A Hanley; Dieter Felsenberg; Laurie K McCauley; Felice O'Ryan; Ian R Reid; Salvatore L Ruggiero; Akira Taguchi; Sotirios Tetradis; Nelson B Watts; Maria Luisa Brandi; Edmund Peters; Teresa Guise; Richard Eastell; Angela M Cheung; Suzanne N Morin; Basel Masri; Cyrus Cooper; Sarah L Morgan; Barbara Obermayer-Pietsch; Bente L Langdahl; Rana Al Dabagh; K Shawn Davison; David L Kendler; George K Sándor; Robert G Josse; Mohit Bhandari; Mohamed El Rabbany; Dominique D Pierroz; Riad Sulimani; Deborah P Saunders; Jacques P Brown; Juliet Compston
Journal:  J Bone Miner Res       Date:  2015-01       Impact factor: 6.741

View more
  4 in total

Review 1.  Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  J I Aguirre; E J Castillo; D B Kimmel
Journal:  Bone       Date:  2021-09-11       Impact factor: 4.398

2.  Altered collagen chemical compositional structure in osteopenic women with past fractures: A case-control Raman spectroscopic study.

Authors:  Gurjit S Mandair; Mohammed P Akhter; Francis W L Esmonde-White; Joan M Lappe; Susan P Bare; William R Lloyd; Jason P Long; Jessica Lopez; Kenneth M Kozloff; Robert R Recker; Michael D Morris
Journal:  Bone       Date:  2021-04-14       Impact factor: 4.626

3.  Influence of direct prostheses on the condition of the alveolar processes during dental implantation.

Authors:  Vitaliy H Shuturminskiy; Vasil A Labunets; Aleksej V Kirichek
Journal:  Saudi Dent J       Date:  2021-10-14

Review 4.  Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  Ran Yan; Ruixue Jiang; Longwei Hu; Yuwei Deng; Jin Wen; Xinquan Jiang
Journal:  Int J Oral Sci       Date:  2022-08-10       Impact factor: 24.897

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.